| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | myo-inositol | 1348 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 1576 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 1619 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 1720 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 1839 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 2298 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 2494 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 3698 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 3706 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 3741 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 3862 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 4215 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 5565 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 5630 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 6312 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 6681 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 7010 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 7457 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 7531 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 7893 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 9829 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 10593 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 11717 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 12488 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | myo-inositol | 12582 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 13904 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | myo-inositol | 14858 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 16614 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 17738 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 21700 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 23878 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 27956 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | myo-inositol | 29121 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 30699 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 31949 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 32188 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 33013 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 33631 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 34845 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 35643 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 35884 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 35964 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 36334 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 36835 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 37122 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 45405 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | myo-inositol | 47169 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 50022 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 58929 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 68742 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 71466 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 75455 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | myo-inositol | 97357 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | myo-inositol | 101536 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|